Article Details
Retrieved on: 2022-10-25 15:42:52
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Pharma major AstraZeneca on Tuesday announced that its asthma drug Fasenra failed to meet one of two main goals of a late-stage study assessing ...
Article found on: www.financialexpress.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here